Q2 2025 13F Holders as of 30 Jun 2025
-
Type / Class
-
Equity / Common Stock, par value $0.01 per share
-
Shares outstanding
-
107M
-
Number of holders
-
114
-
Total 13F shares, excl. options
-
71.3M
-
Shares change
-
-981K
-
Total reported value, excl. options
-
$155M
-
Value change
-
-$4.61M
-
Number of buys
-
62
-
Number of sells
-
-50
-
Price
-
$2.18
Significant Holders of MAXCYTE, INC. - Common Stock, par value $0.01 per share (MXCT) as of Q2 2025
130 filings reported holding MXCT - MAXCYTE, INC. - Common Stock, par value $0.01 per share as of Q2 2025.
MAXCYTE, INC. - Common Stock, par value $0.01 per share (MXCT) has 114 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 71.3M shares
of 107M outstanding shares and own 66.74% of the company stock.
Largest 10 shareholders include BlackRock, Inc. (10.2M shares), CADIAN CAPITAL MANAGEMENT, LP (8.91M shares), MORGAN STANLEY (7.03M shares), MIRABELLA FINANCIAL SERVICES LLP (6.6M shares), VANGUARD GROUP INC (5.6M shares), Vitruvian Partners LLP (5.04M shares), Mudita Advisors LLP (3.37M shares), GEODE CAPITAL MANAGEMENT, LLC (2.48M shares), AXA S.A. (2.2M shares), and STATE STREET CORP (2.18M shares).
This table shows the top 114 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.